Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1984 Oct;20(4):672–676. doi: 10.1128/jcm.20.4.672-676.1984

Comparison of radioimmunoassay and enzyme-linked immunosorbent assay in measurement of antibodies to Neisseria meningitidis group A capsular polysaccharide.

E C Beuvery, M H Kayhty, A B Leussink, V Kanhai
PMCID: PMC271408  PMID: 6436314

Abstract

Antibodies to meningococcal group A polysaccharide were determined by radioimmunoassay (RIA) and enzyme-linked immunosorbent assay (ELISA) in serum samples from 16 adults vaccinated with bivalent meningococcal group A and C polysaccharide vaccine. The specific antibody levels in the serum samples were expressed as micrograms of antibody protein per milliliter of serum. For RIA the polysaccharide was radiolabeled extrinsically with 125I. Both native polysaccharide and polysaccharide labeled with 127I were used in ELISA. Because these antigens gave similar results, it can be concluded that the introduction of tyramine and iodine by the labeling procedure did not alter the antigenic activity of the polysaccharide. The reproducibility of RIA was clearly better than that of ELISA. The antibody levels detected by the methods were equal, which means that ELISA can be used satisfactorily to measure antibodies to meningococcal group A polysaccharide quantitatively. Some discrepant results were found due to an underestimation of immunoglobulin M antibodies in ELISA. This was shown by a correlation test in which a weakly significant negative correlation was found between the immunoglobulin M antibody level/immunoglobulin G antibody level ratio and the RIA antibody level/ELISA antibody level ratio.

Full text

PDF
672

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Axén R., Ernback S. Chemical fixation of enzymes to cyanogen halide activated polysaccharide carriers. Eur J Biochem. 1971 Feb 1;18(3):351–360. doi: 10.1111/j.1432-1033.1971.tb01250.x. [DOI] [PubMed] [Google Scholar]
  2. Basta M. T., Russell H., Guirguis N. I., Hafez K., El Kholy A. Enzyme-linked immunosorbent assay for determination of human antibodies to group C meningococcal polysaccharide. Proc Soc Exp Biol Med. 1982 Jan;169(1):7–11. doi: 10.3181/00379727-169-41299. [DOI] [PubMed] [Google Scholar]
  3. Beuvery E. C., Leussink A. B., Van Delft R. W., Tiesjema R. H., Nagel J. Immunoglobulin M and G antibody responses and persistence of these antibodies in adults after vaccination with a combined meningococcal group A and group C polysaccharide vaccine. Infect Immun. 1982 Aug;37(2):579–585. doi: 10.1128/iai.37.2.579-585.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Beuvery E. C., van Delft R. W., Tiesjema R. H., Nagel J. The enzyme-linked immunosorbent assay of meningococcal and some related Escherichia coli polysaccharides. J Biol Stand. 1983 Jul;11(3):195–204. doi: 10.1016/s0092-1157(83)80006-7. [DOI] [PubMed] [Google Scholar]
  5. Bundle D. R., Smith I. C., Jennings H. J. Determination of the structure and conformation of bacterial polysaccharides by carbon 13 nuclear magnetic resonance. Studies on the group-specific antigens of Neisseria meningitidis serogroups A and X. J Biol Chem. 1974 Apr 10;249(7):2275–2281. [PubMed] [Google Scholar]
  6. Cisar J., Kabat E. A., Dorner M. M., Liao J. Binding properties of immunoglobulin combining sites specific for terminal or nonterminal antigenic determinants in dextran. J Exp Med. 1975 Aug 1;142(2):435–459. doi: 10.1084/jem.142.2.435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fraker P. J., Speck J. C., Jr Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril. Biochem Biophys Res Commun. 1978 Feb 28;80(4):849–857. doi: 10.1016/0006-291x(78)91322-0. [DOI] [PubMed] [Google Scholar]
  8. Gold R., Lepow M. L., Goldschneider I., Draper T. F., Gotschlich E. C. Antibody responses of human infants to three doses of group A Neisseria meningitidis polysaccharide vaccine administered at two, four, and six months of age. J Infect Dis. 1978 Dec;138(6):731–735. doi: 10.1093/infdis/138.6.731. [DOI] [PubMed] [Google Scholar]
  9. Goldschneider I., Gotschlich E. C., Artenstein M. S. Human immunity to the meningococcus. II. Development of natural immunity. J Exp Med. 1969 Jun 1;129(6):1327–1348. doi: 10.1084/jem.129.6.1327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gotschlich E. C., Goldschneider I., Artenstein M. S. Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers. J Exp Med. 1969 Jun 1;129(6):1367–1384. doi: 10.1084/jem.129.6.1367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gotschlich E. C., Liu T. Y., Artenstein M. S. Human immunity to the meningococcus. 3. Preparation and immunochemical properties of the group A, group B, and group C meningococcal polysaccharides. J Exp Med. 1969 Jun 1;129(6):1349–1365. doi: 10.1084/jem.129.6.1349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Griffiss J. M., Brandt B. L., Altieri P. L., Pier G. B., Berman S. L. Safety and immunogenicity of a group 29E meningococcal capsular polysaccharide vaccine in adults. Infect Immun. 1983 Jan;39(1):247–252. doi: 10.1128/iai.39.1.247-252.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Griffiss J. M., Brandt B. L., Altieri P. L., Pier G. B., Berman S. L. Safety and immunogenicity of group Y and group W135 meningococcal capsular polysaccharide vaccines in adults. Infect Immun. 1981 Dec;34(3):725–732. doi: 10.1128/iai.34.3.725-732.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Griffiss J. M., Brandt B. L., Broud D. D. Human immune response to various doses of group Y and W135 meningococcal polysaccharide vaccines. Infect Immun. 1982 Jul;37(1):205–208. doi: 10.1128/iai.37.1.205-208.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hill H. R., Matsen J. M. Enzyme-linked immunosorbent assay and radioimmunoassay in the serologic diagnosis of infectious diseases. J Infect Dis. 1983 Feb;147(2):258–263. doi: 10.1093/infdis/147.2.258. [DOI] [PubMed] [Google Scholar]
  16. Kohn J., Wilchek M. Procedures for the analysis of cyanogen bromide-activated Sepharose or Sephadex by quantitative determination of cyanate esters and imidocarbonates. Anal Biochem. 1981 Aug;115(2):375–382. doi: 10.1016/0003-2697(81)90020-8. [DOI] [PubMed] [Google Scholar]
  17. Käyhty H. Comparison of passive hemagglutination, bactericidal activity, and radioimmunological methods in measuring antibody responses to Neisseria meningitidis group A capsular polysaccharide vaccine. J Clin Microbiol. 1980 Aug;12(2):256–263. doi: 10.1128/jcm.12.2.256-263.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Käyhty H., Jousimies-Somer H., Peltola H., Mäketä P. H. Antibody response to capsular polysaccharides of groups A and C neisseria meningitidis and Haemophilus influenzae type b during bacteremic disease. J Infect Dis. 1981 Jan;143(1):32–41. doi: 10.1093/infdis/143.1.32. [DOI] [PubMed] [Google Scholar]
  19. Käyhty H., Karanko V., Peltola H., Sarna S., Mäkelä P. H. Serum antibodies to capsular polysaccharide vaccine of group A Neissera meningitidis followed for three years in infants and children. J Infect Dis. 1980 Dec;142(6):861–868. doi: 10.1093/infdis/142.6.861. [DOI] [PubMed] [Google Scholar]
  20. Käyhty H. The unspecific antibody response to N. meningitidis group A capsular polysaccharide often seen in bacteraemic diseases. Parasite Immunol. 1982 May;4(3):157–170. doi: 10.1111/j.1365-3024.1982.tb00428.x. [DOI] [PubMed] [Google Scholar]
  21. Mäkelä P. H., Peltola H., Käyhty H., Jousimies H., Pettay O., Ruoslahti E., Sivonen A., Renkonen O. V. Polysaccharide vaccines of group A Neisseria meningtitidis and Haemophilus influenzae type b: a field trial in Finland. J Infect Dis. 1977 Aug;136 (Suppl):S43–S50. doi: 10.1093/infdis/136.supplement.s43. [DOI] [PubMed] [Google Scholar]
  22. NISONOFF A., WISSLER F. C., LIPMAN L. N. Properties of the major component of a peptic digest of rabbit antibody. Science. 1960 Dec 9;132(3441):1770–1771. doi: 10.1126/science.132.3441.1770. [DOI] [PubMed] [Google Scholar]
  23. Pedersen F. K., Henrichsen J., Schiffman G. Comparison of enzyme-linked immunosorbent assay and radioimmunoassay for determination of anti-pneumococcal polysaccharide antibodies. Acta Pathol Microbiol Immunol Scand C. 1983 Aug;91(4):251–255. [PubMed] [Google Scholar]
  24. Roberts R. B. The relationship between group A and group C meningococcal polysaccharides and serum opsonins in man. J Exp Med. 1970 Mar 1;131(3):499–513. doi: 10.1084/jem.131.3.499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Tramont E. C., Artenstein M. S. Latex agglutination test for measurement of antibodies to meningococcal polysaccharides. Infect Immun. 1972 Mar;5(3):346–351. doi: 10.1128/iai.5.3.346-351.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES